KININS MEDIATE KALLIKREIN-INDUCED ENDOTHELIUM-DEPENDENT RELAXATIONS IN ISOLATED CANINE CORONARY-ARTERIES

被引:35
作者
MOMBOULI, JV
VANHOUTTE, PM
机构
[1] Center For Experimental Therapeutics, Baylor College of Medicine, Houston
关键词
D O I
10.1016/0006-291X(92)91681-F
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ACE inhibitors elicit the release of endothelium-derived relaxing factors in perfused isolated canine arteries (Mombouli and Vanhoutte, J.Cardiovasc.Pharmacol.1991, 18: 926-927); this action is antagonized by bradykinin-receptor antagonists suggesting that it is mediated by local kinin generation. The effects of exogenous tissular kallikrein (porcine) were examined in vitro in the isolated canine coronary artery. Isometric tension was measured in blood vessel rings (with and without endothelium) contracted with prostaglandin F2α. The kallikrein elicited relaxations in rings with, but not in those without, endothelium. This response was augmented by the angiotensin converting enzyme inhibitor perindoprilat, and it was antagonized by the selective B2-kinin receptor antagonist HOE 140 and aprotinin, an inhibitor of tissular kallikrein. These data suggest that in the canine coronary artery, kallikrein causes relaxations that may be mediated by kinins generated from endogenous kininogens present in the vascular wall. © 1992.
引用
收藏
页码:693 / 697
页数:5
相关论文
共 29 条
[1]  
BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126
[2]  
CARRETERO OA, 1991, HYPERTENSION S1, V18, P158
[3]  
CHERRY PD, 1982, P NATL ACAD SCI USA, V79, P2105
[4]   CHARACTERIZATION OF A FUNCTIONAL THROMBIN RECEPTOR - ISSUES AND OPPORTUNITIES [J].
COUGHLIN, SR ;
VU, TKH ;
HUNG, DT ;
WHEATON, VI .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :351-355
[5]  
DEMEY JG, 1982, J PHARMACOL EXP THER, V222, P166
[6]   ANGIOTENSIN-I CONVERTING ENZYME AND THE CHANGES IN OUR CONCEPTS THROUGH THE YEARS - DAHL,LEWIS,K. MEMORIAL LECTURE [J].
ERDOS, EG .
HYPERTENSION, 1990, 16 (04) :363-370
[7]  
FAHRY RD, 1992, BIOCHEM BIOPH RES CO, V182, P283
[8]   IDENTIFICATION OF A TISSUE KALLIKREIN IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
FIGUEROA, CD ;
MACIVER, AG ;
BHOOLA, KD .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (03) :321-328
[9]  
LAUBIE M, 1984, J CARDIOVASC PHARM, V6, P1076
[10]   LOCAL INHIBITION OF BRADYKININ DEGRADATION IN ISCHEMIC HEARTS [J].
LINZ, W ;
MARTORANA, PA ;
SCHOLKENS, BA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S99-S109